Benzodiazepines and Risk of Pneumonia in Schizophrenia: a Nationwide Case-control Study

Overview

Journal Psychopharmacology (Berl)

Specialty Pharmacology

Date 2018 Sep 21

PMID 30232530

Citations 5

Authors

Sheng-Yun Cheng

Wen-Yin Chen

Hsing-Cheng Liu

Tien-Wei Yang

Chun-Hung Pan

Shu-Yu Yang

Chian-Jue Kuo

Affiliations

Soon will be listed here.

Abstract

Objectives: To investigate the relationship between benzodiazepine and risk of developing pneumonia in patients with schizophrenia, whose benzodiazepine dosage and usage frequency was higher than that of the general population.

Methods: We conducted a nested case-control study to assess the association between benzodiazepine use and pneumonia among patients with schizophrenia. By using the Taiwan National Health Insurance Research Database, we identified a schizophrenia cohort comprising 34,929 patients during 2000-2010. Within the schizophrenia cohort, 2501 cases of pneumonia and 9961 matched control patients (1:4 ratio) were identified. Benzodiazepine exposure was categorized by drug, treatment duration, and daily dose. Conditional logistic regression models were used to examine the association between benzodiazepine exposure and the risk of pneumonia.

Results: The current use (within 30 days) of midazolam led to the highest pneumonia risk (adjusted risk ratio = 6.56, P < 0.001), followed by diazepam (3.43, P < 0.001), lorazepam (2.16, P < 0.001), and triazolam (1.80, P = 0.019). Furthermore, nearly all the benzodiazepines under current use had a dose-dependent effect on pneumonia risk. The risk of pneumonia was correlated with the affinities of γ-aminobutyric acid A α1, α2, and α3 receptors.

Conclusions: Benzodiazepines had a dose-dependent relationship with pneumonia in patients with schizophrenia. The differences in risk and mechanism of action of the individual drugs require further investigation. Clinicians should be aware of the early signs of pneumonia in patients with schizophrenia receiving benzodiazepines.

Citing Articles

Analysis of risk factors for hospital-acquired pneumonia in schizophrenia.

Chen Y, Ren C, Liao Y Front Psychiatry. 2024; 15:1414332.

PMID: 39220180 PMC: 11362047. DOI: 10.3389/fpsyt.2024.1414332.

Seasonal characteristics of nosocomial infection in a psychiatric hospital in China with different nosocomial prevention and control backgrounds: a retrospective study.

Zhou Y, Chen S, Wang Y, Liang J, Li H, Shi H Sci Rep. 2024; 14(1):17045.

PMID: 39048616 PMC: 11269690. DOI: 10.1038/s41598-024-65368-8.

A real-world pharmacovigilance study of FDA adverse event reporting system events for diazepam.

He W, Wang Y, Chen K Front Pharmacol. 2024; 15:1278442.

PMID: 38327980 PMC: 10847318. DOI: 10.3389/fphar.2024.1278442.

Non-antipsychotic medicines and modified electroconvulsive therapy are risk factors for hospital-acquired pneumonia in schizophrenia patients.

Yang Y, Kong D, Li Q, Chen W, Zhao G, Tan X Front Psychiatry. 2023; 13:1071079.

PMID: 36713903 PMC: 9880231. DOI: 10.3389/fpsyt.2022.1071079.

Development and validation of the UPLC-MS method for simultaneous determination of six new psychoactive substances.

Tan Z, Wen Y, Yang K, Zhao X, Yang X, He J RSC Adv. 2022; 12(41):26704-26711.

PMID: 36320845 PMC: 9490772. DOI: 10.1039/d2ra04869h.

References

Akritopoulou K, Iakovidou-Kritsi Z, Mioglou-Kalouptsi E, Ekonomopoulou M, Mourelatos D . Cytogenetic activity of diazepam in normal human lymphocyte cultures. Genet Test Mol Biomarkers. 2009; 13(2):227-31. DOI: 10.1089/gtmb.2008.0116. View

Partti K, Vasankari T, Kanervisto M, Perala J, Saarni S, Jousilahti P . Lung function and respiratory diseases in people with psychosis: population-based study. Br J Psychiatry. 2015; 207(1):37-45. DOI: 10.1192/bjp.bp.113.141937. View

Miyawaki T, Sogawa N, Maeda S, Kohjitani A, Shimada M . Effect of midazolam on interleukin-6 mRNA expression in human peripheral blood mononuclear cells in the absence of lipopolysaccharide. Cytokine. 2001; 15(6):320-7. DOI: 10.1006/cyto.2001.0940. View

Mohler H, Fritschy J, Rudolph U . A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2001; 300(1):2-8. DOI: 10.1124/jpet.300.1.2. View

Wagner A, Zhang F, Soumerai S, Walker A, Gurwitz J, Glynn R . Benzodiazepine use and hip fractures in the elderly: who is at greatest risk?. Arch Intern Med. 2004; 164(14):1567-72. DOI: 10.1001/archinte.164.14.1567. View

Morrison A, Wells A . Relationships between worry, psychotic experiences and emotional distress in patients with schizophrenia spectrum diagnoses and comparisons with anxious and non-patient groups. Behav Res Ther. 2007; 45(7):1593-600. DOI: 10.1016/j.brat.2006.11.010. View

Olfson M, Gerhard T, Huang C, Crystal S, Stroup T . Premature Mortality Among Adults With Schizophrenia in the United States. JAMA Psychiatry. 2015; 72(12):1172-81. DOI: 10.1001/jamapsychiatry.2015.1737. View

Papadopoulos V, Baraldi M, Guilarte T, Knudsen T, Lacapere J, Lindemann P . Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci. 2006; 27(8):402-9. DOI: 10.1016/j.tips.2006.06.005. View

Maddalena A, Fox M, Hofmann M, Hock C . Esophageal dysfunction on psychotropic medication. A case report and literature review. Pharmacopsychiatry. 2004; 37(3):134-8. DOI: 10.1055/s-2004-818993. View

10.

HENTSCHEL H, Sastre y Hernandez M, Fichte K . [Lormetazepam in the treatment of sleep disorders in a medical practice; double-blind test on 100 patients (author's transl)]. Dtsch Med Wochenschr. 1981; 106(22):711-4. DOI: 10.1055/s-2008-1070387. View

11.

Wu C, Lin Y, Liu S . Benzodiazepine use among patients with schizophrenia in Taiwan: a nationwide population-based survey. Psychiatr Serv. 2011; 62(8):908-14. DOI: 10.1176/ps.62.8.pss6208_0908. View

12.

Wei M, Li L, Meng R, Fan Y, Liu Y, Tao L . Suppressive effect of diazepam on IFN-gamma production by human T cells. Int Immunopharmacol. 2009; 10(3):267-71. DOI: 10.1016/j.intimp.2009.11.009. View

13.

Felthous A . Schizophrenia and impulsive aggression: a heuristic inquiry with forensic and clinical implications. Behav Sci Law. 2008; 26(6):735-58. DOI: 10.1002/bsl.846. View

14.

Obiora E, Hubbard R, Sanders R, Myles P . The impact of benzodiazepines on occurrence of pneumonia and mortality from pneumonia: a nested case-control and survival analysis in a population-based cohort. Thorax. 2012; 68(2):163-70. DOI: 10.1136/thoraxjnl-2012-202374. View

15.

Wysowski D, Baum C, Ferguson W, Lundin F, Ng M, Hammerstrom T . Sedative-hypnotic drugs and the risk of hip fracture. J Clin Epidemiol. 1996; 49(1):111-3. DOI: 10.1016/0895-4356(95)00057-7. View

16.

Hardemark Cedborg A, Sundman E, Boden K, Hedstrom H, Kuylenstierna R, Ekberg O . Effects of morphine and midazolam on pharyngeal function, airway protection, and coordination of breathing and swallowing in healthy adults. Anesthesiology. 2015; 122(6):1253-67. DOI: 10.1097/ALN.0000000000000657. View

17.

Brookhuis K, Volkerts E, OHanlon J . Repeated dose effects of lormetazepam and flurazepam upon driving performance. Eur J Clin Pharmacol. 1990; 39(1):83-7. DOI: 10.1007/BF02657065. View

18.

Ray W, Griffin M, Downey W . Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA. 1989; 262(23):3303-7. View

19.

Kumari V, Barkataki I, Goswami S, Flora S, Das M, Taylor P . Dysfunctional, but not functional, impulsivity is associated with a history of seriously violent behaviour and reduced orbitofrontal and hippocampal volumes in schizophrenia. Psychiatry Res. 2009; 173(1):39-44. DOI: 10.1016/j.pscychresns.2008.09.003. View

20.

Kuo C, Yang S, Liao Y, Chen W, Lee W, Shau W . Second-generation antipsychotic medications and risk of pneumonia in schizophrenia. Schizophr Bull. 2012; 39(3):648-57. PMC: 3627761. DOI: 10.1093/schbul/sbr202. View